Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Brötz-Oesterhelt

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Current Opinion in Microbiology|August 13, 2013
Bacterial cell division as a target for new antibioticsPeter Sass, Heike Brötz-Oesterhelt
Future Microbiology|November 16, 2010
Postgenomic strategies in antibacterial drug discoveryHeike Brötz-Oesterhelt, Peter Sass
Drug Discovery Today|July 5, 2005
Functional genomics in antibacterial drug discoveryChristoph Freiberg, Heike Brötz-Oesterhelt
International Journal of Medical Microbiology : IJMM|October 15, 2013
Bacterial caseinolytic proteases as novel targets for antibacterial treatmentHeike Brötz-Oesterhelt, Peter Sass
Frontiers in Molecular Biosciences|June 10, 2021
Reprogramming of the Caseinolytic Protease by ADEP Antibiotics: Molecular Mechanism, Cellular Consequences, Therapeutic PotentialHeike Brötz-Oesterhelt, Andreas Vorbach
Current Opinion in Pharmacology|July 16, 2008
How many modes of action should an antibiotic have?Heike Brötz-Oesterhelt, Nina A Brunner
Current Opinion in Microbiology|September 29, 2004
The impact of transcriptome and proteome analyses on antibiotic drug discoveryChristoph Freiberg, Heike Brötz-Oesterhelt, Harald Labischinski
International Journal of Medical Microbiology : IJMM|July 24, 2019
Consequences of dosing and timing on the antibacterial effects of ADEP antibioticsChristian Mayer, Peter Sass, Heike Brötz-Oesterhelt
Methods in Molecular Medicine|April 26, 2008
Methods to assay inhibitors of tRNA synthetase activityDieter Beyer, Hein Peter Kroll, Heike Brötz-Oesterhelt
Mass Spectrometry Reviews|September 25, 2004
Bacterial proteomics and its role in antibacterial drug discoveryHeike Brötz-Oesterhelt, Julia Elisabeth Bandow, Harald Labischinski
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Opinion in Microbiology|August 13, 2013
Bacterial cell division as a target for new antibioticsPeter Sass, Heike Brötz-Oesterhelt
Future Microbiology|November 16, 2010
Postgenomic strategies in antibacterial drug discoveryHeike Brötz-Oesterhelt, Peter Sass
Drug Discovery Today|July 5, 2005
Functional genomics in antibacterial drug discoveryChristoph Freiberg, Heike Brötz-Oesterhelt
International Journal of Medical Microbiology : IJMM|October 15, 2013
Bacterial caseinolytic proteases as novel targets for antibacterial treatmentHeike Brötz-Oesterhelt, Peter Sass
Frontiers in Molecular Biosciences|June 10, 2021
Reprogramming of the Caseinolytic Protease by ADEP Antibiotics: Molecular Mechanism, Cellular Consequences, Therapeutic PotentialHeike Brötz-Oesterhelt, Andreas Vorbach
Current Opinion in Pharmacology|July 16, 2008
How many modes of action should an antibiotic have?Heike Brötz-Oesterhelt, Nina A Brunner
Current Opinion in Microbiology|September 29, 2004
The impact of transcriptome and proteome analyses on antibiotic drug discoveryChristoph Freiberg, Heike Brötz-Oesterhelt, Harald Labischinski
International Journal of Medical Microbiology : IJMM|July 24, 2019
Consequences of dosing and timing on the antibacterial effects of ADEP antibioticsChristian Mayer, Peter Sass, Heike Brötz-Oesterhelt
Methods in Molecular Medicine|April 26, 2008
Methods to assay inhibitors of tRNA synthetase activityDieter Beyer, Hein Peter Kroll, Heike Brötz-Oesterhelt
Mass Spectrometry Reviews|September 25, 2004
Bacterial proteomics and its role in antibacterial drug discoveryHeike Brötz-Oesterhelt, Julia Elisabeth Bandow, Harald Labischinski
Pageof 10